Alzheimer's drug, from $BIIB and Eisai

NASDAQ:BIIB   Biogen Inc.
According to MarketWatch, The FDA approved the
Alzheimer's drug Legembi from
Eisai and Biogen

A quick look at the daily charts for $BIIB shows that it's already trading on or above major moving averages (ie. 9,21,50 SMA's). Also, seeing as this is a nice, green day for the SPY and BIIB has been beaten down recently, it's a nice long option for medium term traders and investors in general.

If I were to go long, a nice R:R profit target would be the top of the Bollinger bands with a stop loss below the "fast" moving average in use.
Good luck.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.